Yangbing Li

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Tyrosine Kinase

Small Cell Lung Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for locally advanced or metastatic ROS1-positive non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Michael I Barbato, Diana Bradford, Yi Ren, Stephanie L Aungst, Claudia P Miller, Lili Pan, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jianghong Fan, Manuela Grimstein, Sarah E Dorff, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Peter Schotland, Opeyemi Udoka, Idara Ojofeitimi, John K Leighton, Nam Atiqur Rahman, Richard Pazdur, Harpreet Singh, Paul G Kluetz, Nicole Drezner
FDA Approval Summary: Repotrectinib for Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (16) (2024)
Michael I Barbato, Jeannette Nashed, Diana Bradford, Yi Ren, Sachia Khasar, Claudia P Miller, Banu S Zolnik, Hong Zhao, Yangbing Li, Youwei Bi, Stacy S Shord, Anup K Amatya, Pallavi S Mishra-Kalyani, Barbara Scepura, Raniya A Al-Matari, Richard Pazdur, Paul G Kluetz, Martha Donoghue, Harpreet Singh, Nicole Drezner
FDA Approval Summary: Dabrafenib in combination with trametinib for BRAF V600E mutation-positive low-grade glioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sandra J Casak, M Naomi Horiba, Mengdie Yuan, Joyce Cheng, Steven J Lemery, Yuan Li Shen, Wentao Fu, Jason N Moore, Yangbing Li, Youwei Bi, Doris Auth, Nataliya Fesenko, Paul G Kluetz, Richard Pazdur, Lola A Fashoyin-Aje
FDA Approval Summary: Tucatinib with trastuzumab for advanced unresectable or metastatic, chemotherapy refractory, HER2 positive RAS wild type colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Katie Chon, Erin Larkins, Somak Chatterjee, Pallavi S Mishra-Kalyani, Stephanie L Aungst, Emily Wearne, Sriram Subramaniam, Yangbing Li, Jiang Liu, Jielin Sun, Rosane Charlab, Hong Zhao, Banu Saritas-Yildirim, Rama Kamesh Bikkavilli, Soma Ghosh, Reena Philip, Julia A Beaver, Harpreet Singh
FDA Approval Summary: Amivantamab for the Treatment of patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, Anup K Amatya, Pallavi S Mishra-Kalyani, Emily Nguyen, Lauren S L Price, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
FDA Approval Summary: Selpercatinib for the treatment of advanced RET fusion-positive solid tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Elizabeth S Duke, Diana Bradford, Michelle Marcovitz, Anup K Amatya, Pallavi S Mishra-Kalyani, Emily Nguyen, Lauren S L Price, Jeanne F Zirkelbach, Yangbing Li, Youwei Bi, Jeffrey Kraft, Sarah E Dorff, Barbara Scepura, Maritsa Stephenson, Idara Ojofeitimi, Abhilasha Nair, Yu Han, Zivana Tezak, Steven J Lemery, Richard Pazdur, Erin Larkins, Harpreet Singh
FDA Approval Summary: Selpercatinib for the Treatment of Advanced RET Fusion-Positive Solid Tumors. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Timil H Patel, Leigh Marcus, M Naomi Horiba, Martha Donoghue, Somak Chatterjee, Pallavi S Mishra-Kalyani, Robert N Schuck, Yangbing Li, Xinyuan Zhang, Jeanne F Zirkelbach, Rosane Charlab, Jiang Liu, Yuching Yang, Steven J Lemery, Richard Pazdur, Marc R Theoret, Lola A Fashoyin-Aje
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 fusion or other rearrangement. Clinical cancer research : an official journal of the American Association for Cancer Research (2022)